The Trump administration said it plans to eliminate kickbacks involving pharmacy benefit managers (PBMs) as part of its goal to lower health insurance for Americans. The framework, dubbed the "Great ...
North Chicago-based AbbVie has become the latest drugmaker to reach a deal with the Trump administration on drug prices in exchange for exemptions from tariffs and future price mandates, the company ...
That would-be rival is Xeris's fellow biotech Corcept Therapeutics. Wednesday morning, the company announced that the U.S. Food and Drug Administration (FDA) had not approved its relacorilant, a ...
Nine pharmaceutical companies have agreed to slash prices on their flagship drugs for Medicaid recipients and people who buy the medications in cash, rather than through insurance, as part of a new ...
WASHINGTON, DC - SEPTEMBER 30: U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with the company to lower Medicaid drug prices and to sell certain ...
Daniel Payne reports on how the health industry and Washington influence and impact each other. He joined STAT in 2025 after covering health care at POLITICO. You can reach Daniel on Signal at danielp ...
A scientific research program that's detected toxic metals in illegal anabolic steroids has been caught up in Queensland’s drug check ban. Talks will be held to confirm if the project - called ...
Hosted on MSN
Drug driving now more deadly than drink driving in Queensland as police ramp up testing
More than 1,000 positive roadside drug tests involving cocaine have been recorded by Queensland police since the narcotic was included in the state's testing regime. Police say some drivers have been ...
This article originally appeared on The Conversation. A generic blood pressure drug called prazosin, made by Teva Pharmaceuticals, is being recalled by the Food and Drug Administration because it ...
The Trump administration announced its newest pharmaceutical agreement under its Most Favored Nation policy Thursday, striking deals with Novo Nordisk and Eli Lilly to sell their GLP-1 products at ...
The deal will include lower drug prices for those on Medicare. The Trump administration announced deals on Thursday with pharmaceutical giants Novo Nordisk and Eli Lilly that would lower the cost of ...
The Federal Drug Administration said drugmakers have recalled more than 580,000 bottles of a blood pressure medication over concerns that it may include a cancer-causing chemical. New Jersey-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results